Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019

Detection in two hospitals of transferable ceftazidime-avibactam resistance in Klebsiella pneumoniae due to a novel VEB β-lactamase variant with a Lys234Arg substitution, Greece, 2019

(2020) E. Voulgari et al.   Eurosurveillance

Novel β-lactam-β-lactamase inhibitor combinations: expectations for the treatment of carbapenem-resistant Gram-negative pathogens

(2019) Ilias Karaiskos et al.   Expert Opinion on Drug Metabolism & Toxicology

Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam

(2019) Galani Irene et al.   CLINICAL MICROBIOLOGY AND INFECTION

Nationwide epidemiology of carbapenem resistant Klebsiella pneumoniae isolates from Greek hospitals, with regards to plazomicin and aminoglycoside resistance

(2019) Irene Galani et al.   BMC INFECTIOUS DISEASES

Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa

(2019) Sandra Mikhail et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology and resistance phenotypes of carbapenemase-producing Klebsiella pneumoniae in Greece, 2014 to 2016

(2018) Irene Galani et al.   Eurosurveillance

In vitro interaction of ceftazidime–avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates

(2017) Paolo Gaibani et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate

(2017) Anna Both et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Identification of Novel VEB β-Lactamase Enzymes and Their Impact on Avibactam Inhibition

(2016) Sushmita D. Lahiri et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla KPC-3 Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections

(2016) Ryan K. Shields et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Variants of β-Lactamase KPC-2 That Are Resistant to Inhibition by Avibactam

(2015) Krisztina M. Papp-Wallace et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of the Outer Membrane and Porins in Susceptibility of β-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam

(2015) Jean-Marie Pagès et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

OmpK35 and OmpK36 porin variants associated with specific sequence types ofKlebsiella pneumoniae

(2013) Constantinos C Papagiannitsis et al.   JOURNAL OF CHEMOTHERAPY

Biochemical Study of a New Inhibitor-Resistant  -Lactamase, SHV-84, Produced by a Clinical Escherichia coli Strain

(2010) V. Manageiro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular epidemiology and antimicrobial susceptibility of extended- and broad-spectrum β-lactamase-producing Klebsiella pneumoniae isolated in Portugal

(2009) Nuno Mendonça et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Molecular and Biochemical Characterization of SHV-56, a Novel Inhibitor-Resistant  -Lactamase from Klebsiella pneumoniae

(2008) V. Dubois et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Lys234Arg Substitution in the Enzyme SHV-72 Is a Determinant for Resistance to Clavulanic Acid Inhibition

(2008) N. Mendonca et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY